Isoniazid is one of the first-line drugs for tuberculosis, usually given in combination with rifampicin, pyrazinamide, and ethambutol during the initial phase of treatment. It inhibits mycolic acid synthesis in the Mycobacterium tuberculosis cell wall. Other options listed are not first-line anti-TB drugs.